BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 31263778)

  • 1. Metabolome signature of autism in the human prefrontal cortex.
    Kurochkin I; Khrameeva E; Tkachev A; Stepanova V; Vanyushkina A; Stekolshchikova E; Li Q; Zubkov D; Shichkova P; Halene T; Willmitzer L; Giavalisco P; Akbarian S; Khaitovich P
    Commun Biol; 2019; 2():234. PubMed ID: 31263778
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased number and increased activation state of astrocytes in gray and white matter of the prefrontal cortex in autism.
    Vakilzadeh G; Falcone C; Dufour B; Hong T; Noctor SC; Martínez-Cerdeño V
    Cereb Cortex; 2022 Oct; 32(21):4902-4912. PubMed ID: 35212358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hippocampal Metabolite Profiles in Two Rat Models of Autism: NMR-Based Metabolomics Studies.
    Toczylowska B; Zieminska E; Senator P; Lazarewicz JW
    Mol Neurobiol; 2020 Jul; 57(7):3089-3105. PubMed ID: 32468248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of cannabidivarin (CBDV) on brain excitation and inhibition systems in adults with and without Autism Spectrum Disorder (ASD): a single dose trial during magnetic resonance spectroscopy.
    Pretzsch CM; Voinescu B; Lythgoe D; Horder J; Mendez MA; Wichers R; Ajram L; Ivin G; Heasman M; Edden RAE; Williams S; Murphy DGM; Daly E; McAlonan GM
    Transl Psychiatry; 2019 Nov; 9(1):313. PubMed ID: 31748505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-wide DNA methylation profiling identifies convergent molecular signatures associated with idiopathic and syndromic autism in post-mortem human brain tissue.
    Wong CCY; Smith RG; Hannon E; Ramaswami G; Parikshak NN; Assary E; Troakes C; Poschmann J; Schalkwyk LC; Sun W; Prabhakar S; Geschwind DH; Mill J
    Hum Mol Genet; 2019 Jul; 28(13):2201-2211. PubMed ID: 31220268
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of metabolic pathway disturbances using multimodal metabolomics in autistic disorders in a Middle Eastern population.
    Bitar T; Mavel S; Emond P; Nadal-Desbarats L; Lefèvre A; Mattar H; Soufia M; Blasco H; Vourc'h P; Hleihel W; Andres CR
    J Pharm Biomed Anal; 2018 Apr; 152():57-65. PubMed ID: 29414019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Lack of Alterations in Metabolites in the Medial Prefrontal Cortex and Amygdala, but Their Associations with Autistic Traits, Empathy, and Personality Traits in Adults with Autism Spectrum Disorder: A Preliminary Study.
    Shirayama Y; Matsumoto K; Osone F; Hara A; Guan S; Hamatani S; Muneoka K; Sato K; Okada A; Yokokawa T
    J Autism Dev Disord; 2024 Jan; 54(1):193-210. PubMed ID: 36251207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exceptional evolutionary divergence of human muscle and brain metabolomes parallels human cognitive and physical uniqueness.
    Bozek K; Wei Y; Yan Z; Liu X; Xiong J; Sugimoto M; Tomita M; Pääbo S; Pieszek R; Sherwood CC; Hof PR; Ely JJ; Steinhauser D; Willmitzer L; Bangsbo J; Hansson O; Call J; Giavalisco P; Khaitovich P
    PLoS Biol; 2014 May; 12(5):e1001871. PubMed ID: 24866127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid metabolic evolution in human prefrontal cortex.
    Fu X; Giavalisco P; Liu X; Catchpole G; Fu N; Ning ZB; Guo S; Yan Z; Somel M; Pääbo S; Zeng R; Willmitzer L; Khaitovich P
    Proc Natl Acad Sci U S A; 2011 Apr; 108(15):6181-6. PubMed ID: 21444806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neural signature of developmental coordination disorder in the structural connectome independent of comorbid autism.
    Caeyenberghs K; Taymans T; Wilson PH; Vanderstraeten G; Hosseini H; van Waelvelde H
    Dev Sci; 2016 Jul; 19(4):599-612. PubMed ID: 27147441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cannabidiol on brain excitation and inhibition systems; a randomised placebo-controlled single dose trial during magnetic resonance spectroscopy in adults with and without autism spectrum disorder.
    Pretzsch CM; Freyberg J; Voinescu B; Lythgoe D; Horder J; Mendez MA; Wichers R; Ajram L; Ivin G; Heasman M; Edden RAE; Williams S; Murphy DGM; Daly E; McAlonan GM
    Neuropsychopharmacology; 2019 Jul; 44(8):1398-1405. PubMed ID: 30758329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Layer-Specific Changes in the Prefrontal Glia/Neuron Ratio Characterizes Patches of Gene Expression Disorganization in Children with Autism.
    Rabelo LN; Queiroz JPG; Castro CCM; Silva SP; Campos LD; Silva LC; Nascimento EB; Martínez-Cerdeño V; Fiuza FP
    J Autism Dev Disord; 2023 Sep; 53(9):3648-3658. PubMed ID: 35704132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiles of urine and blood metabolomics in autism spectrum disorders.
    Likhitweerawong N; Thonusin C; Boonchooduang N; Louthrenoo O; Nookaew I; Chattipakorn N; Chattipakorn SC
    Metab Brain Dis; 2021 Oct; 36(7):1641-1671. PubMed ID: 34338974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional Alterations Associated with Structural Abnormalities in Adults with High-Functioning Autism Spectrum Disorder.
    Anteraper SA; Guell X; Hollinshead MO; D'Mello A; Whitfield-Gabrieli S; Biederman J; Joshi G
    Brain Connect; 2020 Sep; 10(7):368-376. PubMed ID: 32517487
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolic profiling in children with autism spectrum disorder with and without mental regression: preliminary results from a cross-sectional case-control study.
    Rangel-Huerta OD; Gomez-Fernández A; de la Torre-Aguilar MJ; Gil A; Perez-Navero JL; Flores-Rojas K; Martín-Borreguero P; Gil-Campos M
    Metabolomics; 2019 Jun; 15(7):99. PubMed ID: 31250215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-dependent brain gene expression and copy number anomalies in autism suggest distinct pathological processes at young versus mature ages.
    Chow ML; Pramparo T; Winn ME; Barnes CC; Li HR; Weiss L; Fan JB; Murray S; April C; Belinson H; Fu XD; Wynshaw-Boris A; Schork NJ; Courchesne E
    PLoS Genet; 2012; 8(3):e1002592. PubMed ID: 22457638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Metabolomics Approach to Screening for Autism Risk in the Children's Autism Metabolome Project.
    Smith AM; Natowicz MR; Braas D; Ludwig MA; Ney DM; Donley ELR; Burrier RE; Amaral DG
    Autism Res; 2020 Aug; 13(8):1270-1285. PubMed ID: 32558271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics Study of Urine in Autism Spectrum Disorders Using a Multiplatform Analytical Methodology.
    Diémé B; Mavel S; Blasco H; Tripi G; Bonnet-Brilhault F; Malvy J; Bocca C; Andres CR; Nadal-Desbarats L; Emond P
    J Proteome Res; 2015 Dec; 14(12):5273-82. PubMed ID: 26538324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteomics and Metabolomics Approaches towards a Functional Insight onto AUTISM Spectrum Disorders: Phenotype Stratification and Biomarker Discovery.
    Ristori MV; Mortera SL; Marzano V; Guerrera S; Vernocchi P; Ianiro G; Gardini S; Torre G; Valeri G; Vicari S; Gasbarrini A; Putignani L
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872562
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gray matter microstructure differences in autistic males: A gray matter based spatial statistics study.
    DiPiero MA; Surgent OJ; Travers BG; Alexander AL; Lainhart JE; Dean Iii DC
    Neuroimage Clin; 2023; 37():103306. PubMed ID: 36587584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.